e-ISSN: Pending
Negative / Null Result ReportOpen accessNeuroscience· cited by 9

Update on the Symptomatic Treatment of Huntington’s Disease: From Pathophysiology to Clinical Practice

Gonzalo Olmedo‐Saura; E Bernardi; Lidia Bojtos; Saül Martínez‐Horta; Javier Pagonabarraga; Jaime Kulisevsky; Jesús Pérez‐Pérez · 2025 · International Journal of Molecular Sciences

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Huntington's disease (HD) is the most common autosomal dominant neurodegenerative disorder, characterized by a triad of motor dysfunction, cognitive decline, and psychiatric disturbances. While recent efforts have focused on developing disease-modifying therapies, no treatment has yet demonstrated clinical efficacy. As a result, symptomatic treatment remains the cornerstone of care. However, high-quality evidence from large randomized trials is limited, and therapeutic decisions must rely on clinical expertise and extrapolation from other neurological or psychiatric conditions. This narrative

Abstract by Gonzalo Olmedo‐Saura; E Bernardi; Lidia Bojtos; Saül Martínez‐Horta; Javier Pagonabarraga; Jaime Kulisevsky; Jesús Pérez‐Pérez, International Journal of Molecular Sciences (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.3390/ijms26136220